Living Donor Lung Transplantation for Pleuroparenchymal Fibroelastosis.

Related Articles

Living Donor Lung Transplantation for Pleuroparenchymal Fibroelastosis.

Ann Thorac Surg. 2016 May;101(5):1970-2

Authors: Hata A, Nakajima T, Yoshida S, Kinoshita T, Terada J, Tatsumi K, Matsumiya G, Date H, Yoshino I

Abstract
We report the first patient with pleuroparenchymal fibroelastosis (PPFE) to undergo living donor bilateral lobar lung transplantation. The patient was diagnosed with secondary PPFE as a late complication of chemotherapy that included high-dose cyclophosphamide for mature B-cell lymphocytic leukemia. Although the patient maintained complete remission, dry cough and back pain appeared 8 years after the chemotherapy. He had repeated bilateral pneumothoraces, and his respiratory condition gradually deteriorated because of progressive pleural thickening and parenchymal fibrosis. He underwent living-donor bilateral lobar lung transplantation with an inverse transplant on the left side.

PMID: 27106430 [PubMed - indexed for MEDLINE]

http://ift.tt/2m6Wt65